Business description: Zydus Lifesciences Limited

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Number of employees: 26,921

Sales by Activity: Zydus Lifesciences Limited

Fiscal Period: March20202021202220232024

Pharmaceuticals

125B 133B 133B 150B 172B

Consumer Products

17.67B 18.41B 19.79B 22.45B 23.12B
See all business segments

Geographical breakdown of sales: Zydus Lifesciences Limited

Fiscal Period: March20202021202220232024

United States

63.04B 65.44B 59.49B 74.87B 87.75B

India

64.42B 64.62B 72.53B 76.4B 80.15B

Others

15.07B 20.96B 20.63B 21.11B 27.57B
See all geographic segments

Managers: Zydus Lifesciences Limited

Director TitleAgeSince
Chief Executive Officer 45 2009-11-26
Director of Finance/CFO - -
Compliance Officer - 2019-02-06
Investor Relations Contact - -
See ZYDUS LIFESCIENCES LIMITED governance

Members of the board: Zydus Lifesciences Limited

Manager TitleAgeSince
Director/Board Member 45 2007-03-31
Director/Board Member 70 1997-07-31
Chairman 72 2011-10-04
Director/Board Member 69 2017-07-11
Director/Board Member 56 2003-08-15
Director/Board Member 73 2018-12-05
Director/Board Member 45 2022-11-28
Director/Board Member 38 2022-11-28
Director/Board Member - 2024-05-16
Composition of the Board of Directors

Shareholders: Zydus Lifesciences Limited

NameEquities%Valuation
754,313,343 74.96 % 8 559 M ₹
Life Insurance Corporation of India (Investment Portfolio)
3.157 %
31,765,310 3.157 % 360 M ₹
Kotak Mahindra Asset Management Co. Ltd.
1.356 %
13,641,512 1.356 % 155 M ₹
PPFAS Asset Management Private Ltd.
0.9318 %
9,375,710 0.9318 % 106 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.4361 %
4,387,998 0.4361 % 50 M ₹
List of ZYDUS LIFESCIENCES LIMITED shareholders

Holdings: Zydus Lifesciences Limited

NameEquities%Valuation
36,647,50957.59%845,689,645 $

Company details: Zydus Lifesciences Limited

Zydus Lifesciences Ltd.

Zydus Corporate Park Scheme No. 63, Survey No. 536

382481, Ahmedabad

+91 79 4804 0000

http://www.zyduscadila.com
address Zydus Lifesciences Limited(ZYDUSLIFE)

Group companies: Zydus Lifesciences Limited

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Other
Food: Major Diversified
Medical Distributors
Zydus Vtec Ltd.
See all subsidiaries

Generic Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.62%+0.31%+37.34%+124.75%11.63B
-0.98%-4.52%+31.99%+105.65%49.1B
+0.15%-4.11%+36.55%+94.38%27.36B
+0.22%+0.76%+33.54% - 18.47B
-0.37%-3.45%+9.92%+58.58%13.51B
-.--%+0.14% - - 6.79B
-.--%-1.95% - - 5.73B
-3.46%-10.11%+60.73%+183.08%4.94B
-0.34%-0.37%-39.24%-41.72%4.86B
+0.19%+0.75%+15.52%+22.20%4.84B
Average -0.60%-2.25%+23.29%+78.13% 14.72B
Weighted average by Cap. -0.52%-2.91%+29.27%+93.09%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
BB
surperformance-ratings-light-chart ZYDUS-LIFESCIENCES-LIMITEMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
1,000.15INR
Average target price
1,079.53INR
Spread / Average Target
+7.94%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. Company Zydus Lifesciences Limited